Linguistic Validation Services

Rigorous linguistic validation for the questionnaires and outcome measures used in multinational clinical research. The Translation Company is a women-owned (WBENC-certified) US firm that has supported regulated life sciences teams since 2005. When a clinical outcome assessment travels into a new language and culture, a plain translation is not enough: the instrument has to measure the same concept, the same way, for every patient in every country. Linguistic validation is the documented process that makes that possible.

Operating to ISO 9001 and ISO 17100 standards · Women-owned (WBENC) · Serving regulated teams since 2005 · Last updated June 2026

Book a consultation with our CEO, Camila Saunier — a working session about your study and instruments, not a sales pitch.

What is linguistic validation?

Linguistic validation is a structured, multi-step methodology for adapting a clinical outcome assessment (COA) so that the translated version is conceptually equivalent to the original and is understood as intended by patients in the target population. It is the standard expected for patient-reported outcomes (PROs) and other instruments used to support endpoints and labeling claims in clinical trials. Unlike a standard translation, it builds in independent checks, reconciliation, and direct testing with patients, and it produces an auditable record at every stage. The goal is not a fluent translation but a measurement instrument that performs equivalently across languages.

The clinical instruments we validate

We work across the full range of clinical outcome assessments and study materials:

• Patient-reported outcomes (PROs) — symptom diaries, quality-of-life questionnaires, and treatment-satisfaction measures
• Clinician-reported outcomes (ClinRO) and observer-reported outcomes (ObsRO)
• Performance outcomes (PerfO) and functional assessments
• Rating scales, screening tools, and diagnostic questionnaires
• Electronic COA (eCOA) screen text and migration content
• Informed consent forms, instructions, and patient-facing study materials

Our linguistic validation process

Our methodology follows the principles of good practice recognized across the industry, including the ISPOR Task Force guidance and the expectations set out in the FDA’s PRO guidance. A typical project moves through these stages:

• Preparation. We review the source instrument, clarify the concept each item is meant to capture, and agree on developer or copyright-holder requirements before any translation begins.
• Two independent forward translations. Two qualified in-country linguists translate the instrument separately into the target language.
• Reconciliation. A third linguist compares both versions and reconciles them into a single agreed forward translation.
• Back translation. An independent translator, working only from the reconciled version, translates it back into the source language.
• Back-translation review. We compare the back translation against the original to detect and resolve any shift in meaning.
• Harmonization. Across all languages in the study, we check that every version is interpreting each item consistently.
• Cognitive debriefing. Trained interviewers test the translation with patients from the target population to confirm the items are clear, relevant, and understood as intended.
• Review and finalization. We incorporate the debriefing findings, proofread the final version, and deliver it with a documented validation report.

Cognitive debriefing

Cognitive debriefing is what separates linguistic validation from translation. A trained interviewer sits with patients who match the trial population and walks through the instrument item by item, checking that each question means the same thing to them that it means in the source. Where a term is confusing, culturally loaded, or simply reads wrong, the finding is documented and the wording is revised and re-checked. This is the step regulators and instrument developers look for, because it provides direct evidence that the translated measure works for real patients.

Regulatory alignment and documentation

Linguistic validation supports the evidence regulators expect when a PRO is used to support an endpoint or a labeling claim. Our processes operate to ISO 9001 and ISO 17100 standards, and we align our methodology to ISPOR good-practice principles and the FDA Patient-Reported Outcome guidance, with attention to EMA expectations for multinational studies. Every project is delivered with a full validation report and, where required, a signed certificate of accuracy. We coordinate with instrument developers and copyright holders on licensing and required methodology, and we handle confidential study material securely, never through public machine-translation tools.

Why research teams choose us

• Women-owned and WBENC-certified. A real advantage for sponsor and CRO supplier-diversity programs.
• Principal-level accountability. You deal with ownership, not a rotating account manager, and qualified buyers can speak with our CEO directly.
• In-country, in-population linguists. Forward translation, reconciliation, back translation, and debriefing are each handled by appropriately qualified specialists, never one person doing everything.
• Audit-ready records. Each step is documented so your validation history stands up to inspection.
• One partner across the program. Pair validation with our clinical trial translation for protocols, consent forms, and CRFs.

Frequently asked questions

How is linguistic validation different from translation?

A translation conveys meaning; linguistic validation proves that a translated instrument measures the same concept the same way across languages, using independent forward and back translation, harmonization, and cognitive debriefing with patients.

Do you perform cognitive debriefing with patients?

Yes. Trained interviewers test the instrument with participants from the target population and document the findings, which we then incorporate into the final version.

Which standards do you follow?

We align to ISPOR good-practice principles and the FDA’s PRO guidance, with attention to EMA expectations, and our processes operate to ISO 9001 and ISO 17100. A validation report and certificate of accuracy are provided.

Can you work with the instrument developer or copyright holder?

Yes. We coordinate licensing, required methodology, and any developer-specific steps before translation begins.

Explore related services

• Clinical trial translation — protocols, informed consent forms, and CRFs.
• Medical & life sciences translation — our full medical practice.
• Pharmaceutical translation — labels, SmPCs, and submissions.
• Life sciences translation — one partner across the industry.

Talk with us about your instruments

Start with a conversation, not a price tag. Book a complimentary strategy session with our CEO, Camila Saunier, best suited to sponsors and CROs looking for a long-term validation partner. Have a study and instrument list ready? Email [email protected] or call 800.725.6498.